Drug Trial Radar · NCT02783625
Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas
Last checked: Nov 20, 2026Latest source record: Apr 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
114
Actual
Start
May 23, 2016
Primary completion
Apr 21, 2026
Study completion Apr 21, 2026
Sponsor
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Dana-Farber Cancer Institute; Stanford University
- First posted
- May 26, 2016
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test the safety of a study drug called duvelisib.
Conditions
- Lymphoma
- Relapsed/Refractory T-cell Lymphomas
Interventions
RomidepsinDrug
BortezomibDrug
duvelisibDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- maximum tolerated dose (MTD)Time frame: 1 year
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Stanford University Medical Center
Stanford, California
Dana Farber Cancer Institute
Boston, Massachusetts
University of Washington School of Medicine in St. Louis
St Louis, Missouri
Washington University School of Medicine
St Louis, Missouri
Memorial Sloan Kettering Cancer Center Basking Ridge (Limited protocol activities)
Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth (Limited protocol activities)
Middletown, New Jersey
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, New Jersey
Memorial Sloan Kettering Cancer Center @ Commack (Limitied protocol activities)
Commack, New York
Memorial Sloan Kettering Westchester (Limited protocol activities)
Harrison, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Memorial Sloan Kettering Nassau (Limited protocol activities)
Uniondale, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.